HLA-A and non-small cell lung carcinoma: IMQLMPFGC neoantigen-specific CD8+ T cells induced from the PBMCs of healthy donors also showed strong recognition and reactivity in vitro to NSCLC cell lines harboring both T790M mutation and HLA-A*02:01 [38].